Considerable interindividual variation in the pharmacokinetics of tolperisone HCl
Bae, JW, Kim, MJ, Park, YS, Myung, CS, Jang, CG, Lee, SY
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2007
42
Effects of CYP2C9 polymorphism on the pharmacokinetics of candesartan in healthy Korean subjects
배정우
ACTA PHARMACOLOGICA SINICA, 2006
43
Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects
배정우
ACTA PHARMACOLOGICA SINICA, 2006
44
Heme oxygenase-1 protects MPTP-induced dopaminergic neuronal death
배정우
ACTA PHARMACOLOGICA SINICA, 2006
45
Effects of CYP2C9 and MDR1 polymorphism on the pharmacokinetics of losartan
배정우
ACTA PHARMACOLOGICA SINICA, 2006
46
Allele and genotype frequencies of CYP2C9 in a Korean population
Bae, JW, Kim, HK, Kim, JH, Yang, SI, Kim, MJ, Jang, CG, Park, YS, Lee, SY
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005
47
PBPK modeling to predict the pharmacokinetics of venlafaxine and its active metabolite in different CYP2D6 genotypes and drug-drug interactions with clarithromycin and paroxetine
배정우
ARCHIVES OF PHARMACAL RESEARCH, 2024
48
Physiologically based pharmacokinetic (PBPK) modeling of pitavastatin in relation to SLCO1B1 genetic polymorphism
배정우
ARCHIVES OF PHARMACAL RESEARCH, 2024
49
PBPK modeling to predict the pharmacokinetics of pantoprazole in different CYP2C19 genotypes
배정우
ARCHIVES OF PHARMACAL RESEARCH, 2024
50
Identification of Potential Biomarkers for Diagnosis of Patients with Methamphetamine Use Disorder